NO20055226L - Fremgangsmate for fremstilling av N-substituerte 2-cyanopyrrolidoner - Google Patents
Fremgangsmate for fremstilling av N-substituerte 2-cyanopyrrolidonerInfo
- Publication number
- NO20055226L NO20055226L NO20055226A NO20055226A NO20055226L NO 20055226 L NO20055226 L NO 20055226L NO 20055226 A NO20055226 A NO 20055226A NO 20055226 A NO20055226 A NO 20055226A NO 20055226 L NO20055226 L NO 20055226L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- substituted
- halogen
- isolation
- reacting
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 238000002955 isolation Methods 0.000 abstract 2
- VLJNHYLEOZPXFW-BYPYZUCNSA-N L-prolinamide Chemical compound NC(=O)[C@@H]1CCCN1 VLJNHYLEOZPXFW-BYPYZUCNSA-N 0.000 abstract 1
- -1 N- (N'-substituted glycyl) -2-cyanopyrrolidine Chemical class 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 239000012024 dehydrating agents Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000003839 salts Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Det er beskrevet en fremgangsmåte for fremstilling av et N-(N'-substituert glycyl)-2- cyanopyrrolidin som omfatter minst (a) omsetning i nærvær av dimetylformamid, av en forbindelse av formel (V) hvor, uavhengig av hverandre, X1 og X3 er halogen, X2 er halogen, OH, O-C(=O)-CH2X3, -O-SO2-(C1.8)alkyl eller -O-SO2-(aryl), med L-prolinamid, etterfulgt av (b) omsetning av den resulterende forbindelsen uten isolering med et dehydratiseringsmiddel, eventuelt etterfulgt av (c) omsetning, i nærvær av en base, av den resulterende forbindelsen uten isolering med et egnet amin og (d) utvinning av den resulterende forbindelsen i fri form eller i syreaddisjonssaltform.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0308854A GB0308854D0 (en) | 2003-04-16 | 2003-04-16 | Organic compounds |
GB0311836A GB0311836D0 (en) | 2003-05-22 | 2003-05-22 | Process for the manufacture of organic compounds |
PCT/EP2004/003980 WO2004092127A1 (en) | 2003-04-16 | 2004-04-15 | Process for the preparation of n-substituted 2-cyanopyrrolidines |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20055226L true NO20055226L (no) | 2005-11-07 |
NO333251B1 NO333251B1 (no) | 2013-04-22 |
Family
ID=33301223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20055226A NO333251B1 (no) | 2003-04-16 | 2005-11-07 | Fremgangsmate for fremstilling av N-substituerte 2-cyanopyrrolidoner |
Country Status (31)
Country | Link |
---|---|
US (1) | US7375238B2 (no) |
EP (1) | EP1620396B1 (no) |
JP (1) | JP4672647B2 (no) |
KR (1) | KR101192538B1 (no) |
AR (1) | AR044019A1 (no) |
AU (2) | AU2004230245B2 (no) |
BR (1) | BRPI0409471B8 (no) |
CA (1) | CA2520128C (no) |
CL (1) | CL2004000804A1 (no) |
CO (1) | CO5700735A2 (no) |
CY (1) | CY1116008T1 (no) |
DK (1) | DK1620396T3 (no) |
EC (1) | ECSP056093A (no) |
ES (1) | ES2531084T3 (no) |
HK (1) | HK1087695A1 (no) |
HR (1) | HRP20150163T1 (no) |
IL (1) | IL170887A (no) |
IS (1) | IS2979B (no) |
MA (1) | MA27765A1 (no) |
MX (1) | MXPA05011073A (no) |
MY (1) | MY139476A (no) |
NO (1) | NO333251B1 (no) |
NZ (1) | NZ542899A (no) |
PE (2) | PE20050021A1 (no) |
PL (1) | PL1620396T3 (no) |
PT (1) | PT1620396E (no) |
RU (1) | RU2369598C2 (no) |
SG (1) | SG160212A1 (no) |
SI (1) | SI1620396T1 (no) |
TW (1) | TWI359135B (no) |
WO (1) | WO2004092127A1 (no) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20050021A1 (es) | 2003-04-16 | 2005-03-15 | Novartis Ag | Procedimiento para la preparacion de 2-cianopirrolidina n-sustituida |
ES2332920T3 (es) | 2004-01-20 | 2010-02-15 | Novartis Ag | Proceso y formulacion de compresion directa. |
GT200600008A (es) | 2005-01-18 | 2006-08-09 | Formulacion de compresion directa y proceso | |
WO2007019255A2 (en) * | 2005-08-04 | 2007-02-15 | Novartis Ag | Salts of vildagliptin |
JP5165584B2 (ja) * | 2006-11-29 | 2013-03-21 | 田辺三菱製薬株式会社 | N−(n’−置換グリシル)−2−シアノピロリジン誘導体の製法 |
AR064833A1 (es) * | 2007-01-10 | 2009-04-29 | Medichem Sa | Un procedimiento para la preparacion de vildagliptin |
CZ2008512A3 (cs) | 2008-08-26 | 2010-03-10 | Zentiva, A. S | Zpusob prípravy vysoce cistého vildagliptinu |
SI2459531T1 (sl) | 2009-07-31 | 2020-02-28 | Krka, D.D., Novo Mesto | Granulat, ki obsega vildagliptin, in postopek njegove priprave |
HUP0900638A2 (en) | 2009-10-07 | 2011-05-30 | Egyt Gyogyszervegyeszeti Gyar | Adducts of inorganic salts basea on vildaelitpin applicable for preparation of pharmaceutical compositions |
IT1400714B1 (it) | 2010-07-06 | 2013-06-28 | Chemelectiva S R L | Processo ed intermedi per la preparazione di un principio attivo. |
HU231050B1 (hu) | 2010-08-19 | 2020-02-28 | Egis Gyógyszergyár Nyrt. | Eljárás gyógyszerhatóanyag előállítására |
ITMI20112224A1 (it) | 2011-12-06 | 2013-06-07 | Chemelectiva S R L | Nuovo processo ed intermedi per la sintesi di vildagliptin |
WO2013179300A2 (en) | 2012-05-04 | 2013-12-05 | Megafine Pharma (P) Ltd. | A process for the preparation of vildagliptin and its intermediate thereof |
CN103922986B (zh) * | 2013-01-16 | 2017-02-15 | 上海彩迩文生化科技有限公司 | 维大列汀及其类似物、中间体及其制备方法和应用 |
WO2015145467A1 (en) * | 2014-03-28 | 2015-10-01 | Laurus Labs Private Limited | An improved process for preparing vildagliptin |
WO2021234430A1 (en) | 2020-05-17 | 2021-11-25 | Lotus International Pte. Ltd. | Modified release dosage form comprising vildagliptin and process for manufacturing the same |
WO2022003405A1 (en) | 2020-07-03 | 2022-01-06 | Savoi Guilherme | One-pot process to obtain a pyrrolidine-2-carbonitrile intermediate compound and industrial scale telescopic process to prepare (2s)-1-[n-(3-hydroxyadamantan-1-yl)glycyl]-2-pyrrolidinecarbonitrile (vildagliptin) using same |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5510369A (en) * | 1994-07-22 | 1996-04-23 | Merck & Co., Inc. | Pyrrolidine thrombin inhibitors |
TW492957B (en) * | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
CO5150173A1 (es) * | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
US6380398B2 (en) | 2000-01-04 | 2002-04-30 | Novo Nordisk A/S | Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV |
WO2001055105A1 (en) * | 2000-01-24 | 2001-08-02 | Novo Nordisk A/S | N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv |
TW583185B (en) * | 2000-06-13 | 2004-04-11 | Novartis Ag | N-(substituted glycyl)-2-cyanopyrrolidines and pharmaceutical composition for inhibiting dipeptidyl peptidase-IV (DPP-IV) or for the prevention or treatment of diseases or conditions associated with elevated levels of DPP-IV comprising the same |
JP2002265439A (ja) * | 2001-03-08 | 2002-09-18 | Mitsubishi Pharma Corp | シアノピロリジン誘導体およびその医薬用途 |
PE20050021A1 (es) | 2003-04-16 | 2005-03-15 | Novartis Ag | Procedimiento para la preparacion de 2-cianopirrolidina n-sustituida |
-
2004
- 2004-04-14 PE PE2004000370A patent/PE20050021A1/es not_active Application Discontinuation
- 2004-04-14 AR ARP040101251A patent/AR044019A1/es not_active Application Discontinuation
- 2004-04-14 PE PE2007000421A patent/PE20081293A1/es not_active Application Discontinuation
- 2004-04-15 TW TW093110566A patent/TWI359135B/zh not_active IP Right Cessation
- 2004-04-15 JP JP2006505132A patent/JP4672647B2/ja not_active Expired - Lifetime
- 2004-04-15 PT PT04727557T patent/PT1620396E/pt unknown
- 2004-04-15 SG SG200716949-3A patent/SG160212A1/en unknown
- 2004-04-15 MY MYPI20041383A patent/MY139476A/en unknown
- 2004-04-15 CA CA2520128A patent/CA2520128C/en not_active Expired - Fee Related
- 2004-04-15 WO PCT/EP2004/003980 patent/WO2004092127A1/en active Application Filing
- 2004-04-15 EP EP04727557.3A patent/EP1620396B1/en not_active Expired - Lifetime
- 2004-04-15 PL PL04727557T patent/PL1620396T3/pl unknown
- 2004-04-15 ES ES04727557T patent/ES2531084T3/es not_active Expired - Lifetime
- 2004-04-15 BR BRPI0409471A patent/BRPI0409471B8/pt not_active IP Right Cessation
- 2004-04-15 AU AU2004230245A patent/AU2004230245B2/en not_active Ceased
- 2004-04-15 RU RU2005135331/04A patent/RU2369598C2/ru active
- 2004-04-15 NZ NZ542899A patent/NZ542899A/en not_active IP Right Cessation
- 2004-04-15 CL CL200400804A patent/CL2004000804A1/es unknown
- 2004-04-15 MX MXPA05011073A patent/MXPA05011073A/es active IP Right Grant
- 2004-04-15 US US10/552,835 patent/US7375238B2/en not_active Expired - Fee Related
- 2004-04-15 SI SI200432220T patent/SI1620396T1/sl unknown
- 2004-04-15 DK DK04727557.3T patent/DK1620396T3/en active
- 2004-04-15 KR KR1020057019568A patent/KR101192538B1/ko active IP Right Review Request
-
2005
- 2005-09-15 IL IL170887A patent/IL170887A/en active IP Right Grant
- 2005-10-12 EC EC2005006093A patent/ECSP056093A/es unknown
- 2005-10-19 MA MA28559A patent/MA27765A1/fr unknown
- 2005-11-03 CO CO05112189A patent/CO5700735A2/es not_active Application Discontinuation
- 2005-11-07 NO NO20055226A patent/NO333251B1/no not_active IP Right Cessation
- 2005-11-10 IS IS8122A patent/IS2979B/is unknown
-
2006
- 2006-07-11 HK HK06107769.8A patent/HK1087695A1/xx not_active IP Right Cessation
-
2008
- 2008-05-22 AU AU2008202278A patent/AU2008202278A1/en not_active Abandoned
-
2015
- 2015-02-10 HR HRP20150163TT patent/HRP20150163T1/hr unknown
- 2015-02-18 CY CY20151100168T patent/CY1116008T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20055226L (no) | Fremgangsmate for fremstilling av N-substituerte 2-cyanopyrrolidoner | |
NO20053890L (no) | Syntese av 4-amino-2-butenolklorider og anvendelse derav for fremstilling av 3-cyanokinoliner | |
EA200700545A1 (ru) | Производные изоксазолина и их применение в качестве гербицидов | |
NO20050650L (no) | Fremgangsmate for selektiv fremstilling av aryl-5-tio- -D-aldoheksopyranosider | |
IS6257A (is) | Frumuviðloðunartálmar | |
NO20060703L (no) | Fremgangsmate for fremstilling av cis-4-fluor-1-prolinderivater | |
DK6384D0 (da) | Disubstituerede prolinderivater, fremgangsmade til fremstilling deraf og deres anvendelse | |
MY138051A (en) | Compounds and processes | |
HUP0201475A2 (hu) | Heteroarilamidin-, metilamidin- és guanidinszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények | |
BG48932A3 (en) | Method for preparing of amide compounds | |
DK1225174T3 (da) | Vandfri mirtazapinkrystaller og fremgangsmåde til fremstilling deraf | |
DK1222160T3 (da) | Fremgangsmåde til fremstilling af substituerede allylaminderivater og salte deraf | |
TNSN05261A1 (en) | Process for the preparation of n-substituted 2-cyanopyrrolidines | |
DE502006005865D1 (de) | Herstellung von 1,7` -dimethyl-2` -propyl-2,5` -bi-1h-benzimidazol | |
BG60267B1 (bg) | Метод за получаване на производни на амидоксим | |
DK0540686T3 (da) | 2-fluorfuranosylderivater og fremgangsmåde til fremstilling af 2-fluorpyrimidin- og 2-fluorpurinnucleosider | |
HUP0102666A2 (hu) | Eljárás 2,4-imidazolidindion-származék előállítására | |
NO961537D0 (no) | Salpetersyreestere fra derivater av 2-(2,6-dihalofenylamino)-fenylacetoksyeddiksyre, og deres fremstillingsprosedyrer | |
DE60325631D1 (de) | Verfahren zur herstellung von 2,6-dihalo-para-trifluoromethylanilin | |
NO934741L (no) | Fremgangsmåte for minimalisering og kontroll av ischemiske og reperfusjonsskade | |
ES469215A1 (es) | Procedimiento para la obtencion de antranilamidas. | |
HUP0203384A2 (hu) | Eljárás ketiminek előállítására | |
ES8601099A1 (es) | Procedimiento para la preparacion de nuevos derivados de n-(metoxifenacil)-amina | |
NO20010332L (no) | Nye derivater av 6-deoksyerytromycin, deres fremstillingsprosess og deres anvendelse som medikamenter | |
DE50206142D1 (de) | Verfahren zur herstellung von 1,3-disubstituierten 2-nitroguanidinen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |